Weight Gain Among Children and Adolescents on Dolutegravir in Spain
Journal of the Pediatric Infectious Diseases Society · 2025
DOI: 10.1093/jpids/piaf110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Blanca Bravo-Queipo-de-Llano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric, Infectious and Tropical Diseases Department, La Paz University Hospital, La Paz Research Institute (IdiPAZ), Madrid, Spain. Hauptthemen laut MEDLINE: HIV Infections, Pediatric Obesity, Dolutegravir, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Carlos III Health Institute, Networked Biomedical Research Centre for Infectious Diseases.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This retrospective real-world study analyzed Body Mass Index (BMI) and obesity in 257 Spanish children/adolescents with HIV receiving dolutegravir (DTG)-based or non-Integrase Strand Transfer Inhibitor regimens over five years. DTG-based regimens increased BMI Z-scores without clear clinical relevance. Continuous monitoring of weight trajectories is essential to protect long-term cardiovascular health in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric, Infectious and Tropical Diseases Department, La Paz University Hospital, La Paz Research Institute (IdiPAZ), Madrid, Spain.
- Autonomous University of Madrid (UAM), Madrid, Spain.
- Networked Biomedical Research Centre for Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.
- Pediatric and Infectious Diseases Department, 12 de Octubre University Hospital, Pediatric Research and Clinical Trials Unit (UPIC), 12 de Octubre Research Institute (I+12), Madrid, Spain.
- Pediatric Department, Complutense University of Madrid (UCM), Madrid, Spain.
- Translational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain.
ORCID-Profile: Blanca Bravo-Queipo-de-Llano, Sergio Serrano-Villar
Förderung
- Carlos III Health Institute
- Networked Biomedical Research Centre for Infectious Diseases
Zitieren
APA
Bravo-Queipo-de-Llano, B., Prieto Tato, L. M., Noguera-Julian, A., Escosa-García, L., Frick, M. A., Bustillo, M., Ramos, J. T., Gavilán Martín, C., Collado-Hernández, P., Navarro Gómez, M., Serrano-Villar, S., Sainz Costa, T., & Pediatric National AIDS Research Network of Spain (CoRISpe) (2025). Weight Gain Among Children and Adolescents on Dolutegravir in Spain. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf110
Vancouver
Bravo-Queipo-de-Llano B, Prieto Tato LM, Noguera-Julian A, Escosa-García L, Frick MA, Bustillo M, et al. Weight Gain Among Children and Adolescents on Dolutegravir in Spain. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf110
BibTeX
@article{BravoQueipodeLlano2025,
author = {Bravo-Queipo-de-Llano, Blanca and Prieto Tato, Luis Manuel and Noguera-Julian, Antoni and Escosa-García, Luis and Frick, Marie Antoinette and Bustillo, Matilde and Ramos, José Tomás and Gavilán Martín, César and Collado-Hernández, Pilar and Navarro Gómez, Marisa and Serrano-Villar, Sergio and Sainz Costa, Talía and Pediatric National AIDS Research Network of Spain (CoRISpe), Pediatric National AIDS Research Network of Spain (CoRISpe)},
title = {Weight Gain Among Children and Adolescents on Dolutegravir in Spain},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2025},
doi = {10.1093/jpids/piaf110}
}
EUVIMED